Can a tiny sugar dose soothe Newborns' heel prick pain?
NCT ID NCT07784322
First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time
Summary
This trial asks whether a smaller 0.2 mL dose of sweet sucrose solution can relieve pain just as well as a larger 0.5 mL dose during routine heel pricks in newborns. Babies up to 28 days old will be randomly assigned to receive one of the two doses before the procedure. Researchers will measure pain scores, crying time, and heart rate to compare the two approaches.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- 24% oral sucrose solution
- What this could lead to
- If the lower dose works as well, it could reduce sugar exposure for newborns while still easing pain during routine heel pricks.
- What could go wrong
- This is a small, early-stage trial, and the lower dose might not provide the same pain relief. Also, results in this specific newborn unit may not apply to all babies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
150 people
The number who actually took part.
- Started
-
Apr 2026
- Finished
-
Jul 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
0 to 28 days
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Gestational age ≥ 37 weeks. * Aged between 0 hours to 28 days old. * Requiring routine heel prick (e.g. newborn screening). * Parents or legal guardians can read / understand Chinese or English Exclusion Criteria: * Diagnosed with severe congenital malformations, neurological disorders, or known metabolic disorders. * Having received any sedatives or analgesics. * Having feeding intolerance or gastrointestinal disease.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pain control in heel prick procedure are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Paediatric, Hospital Authority
Kowloon, 0000, Hong Kong